Powder: -20°C for 3 years | In solvent: -80°C for 1 year
APS6-45 inhibits RAS/MAPK signaling and exhibits anti-tumor activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 74.00 | |
5 mg | In stock | $ 178.00 | |
10 mg | In stock | $ 289.00 | |
25 mg | In stock | $ 528.00 | |
50 mg | In stock | $ 769.00 | |
100 mg | In stock | $ 1,080.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 218.00 |
Description | APS6-45 inhibits RAS/MAPK signaling and exhibits anti-tumor activity. |
In vitro | APS6-45 (1 μM; 1 h) strongly inhibits RAS pathway activity signaling in human MTC cell lines TT and MZ-CRC-1[1]. |
In vivo | APS6-45 did not affect body weight of dosed(10 mg/kg) mice after 30 d.APS6-45 (0.1-160 mg/kg; a single p.o.) does not cause detectable toxic effects in mice[1]. |
Molecular Weight | 548.39 |
Formula | C23H16F8N4O3 |
CAS No. | 2188236-41-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 240mg/mL (437.67mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
APS6-45 2188236-41-9 GPCR/G Protein MAPK Ras calibrated signaling TCI Inhibitor APS-6-45 APS645 Carcinoma Thyroid antitumor Medullary APS6 45 tumor inhibit inhibitor